One single biopsy not sufficient to guide treatment decisions in prostate cancer, say researchers
Friday, September 23, 2016 - 04:01
in Health & Medicine
While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal. Genomic fingerprinting can help predict a tumor's aggressiveness and tailor treatment plans, report researchers.
